Novel heterocyclic hydroxamates as inhibitors of the mycobacterial zinc metalloprotease Zmp1 to probe its mechanism of function
- 5 October 2022
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 244, 114831
Abstract
No abstract availableKeywords
Funding Information
- Univerzita Palackého v Olomouci (JG_2019_002)
- Ministry of Education Youth and Sports of the Czech Republic (LM2018131)
- Research Foundation Flanders (G066619N)
- Bergens Forskningsstiftelse
This publication has 21 references indexed in Scilit:
- Discovery of the first potent and selective Mycobacterium tuberculosis Zmp1 inhibitorBioorganic & Medicinal Chemistry Letters, 2014
- Anti-mycobacterial activity of 1,3-diaryltriazenesEuropean Journal of Medicinal Chemistry, 2014
- 1,2,3,4,8,9,10,11-Octahydrobenzo[j]phenanthridine-7,12-diones as New Leads against Mycobacterium tuberculosisJournal of Medicinal Chemistry, 2014
- Functional characterization of the Mycobacterium tuberculosis zinc metallopeptidase Zmp1 and identification of potential substratesBiological Chemistry, 2012
- 1,4–Diarylpiperazines and analogs as anti-tubercular agents: Synthesis and biological evaluationEuropean Journal of Medicinal Chemistry, 2012
- Crystal Structure of Mycobacterium tuberculosis Zinc-dependent Metalloprotease-1 (Zmp1), a Metalloprotease Involved in PathogenicityJournal of Biological Chemistry, 2011
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Linking Inflammasome Activation and Phagosome MaturationCell Host & Microbe, 2008
- Mycobacterium tuberculosis Prevents Inflammasome ActivationCell Host & Microbe, 2008